```json
{
"content": [
{
"type": "paragraph",
"content": "The Peripheral IV Catheters market, valued at approximately USD 1.8 billion in 2023, represents a critical segment of the global healthcare industry, enabling short-term intravenous therapy for fluid, medication, and blood administration. As a cornerstone of clinical care, this market is driven by rising demand for minimally invasive procedures and the growing prevalence of chronic diseases. The Peripheral IV Catheters market size is projected to grow at a CAGR of 5.2% from 2026 to 2033, reflecting robust industry expansion amid evolving healthcare infrastructure and technological advancements."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["20G", "22G", "24G"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[180, 195, 210, 225, 240, 255, 270, 285, 300, 315, 330, 345, 360], // 20G
[120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240], // 22G
[90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145, 150] // 24G
]
}
},
{
"type": "paragraph",
"content": "Key growth drivers include the adoption of antimicrobial-coated catheters to mitigate bloodstream infections and regulatory shifts prioritizing patient safety. North America remains the largest regional market due to advanced healthcare systems, while Asia-Pacific is the fastest-growing region, fueled by expanding medical facilities and rising disposable incomes. Innovation in catheter design, such as improved material biocompatibility, and increasing procedural adoption in ambulatory care settings are reshaping competitive dynamics. Strategic partnerships among manufacturers and suppliers to streamline supply chains further underscore the market’s resilience amid macroeconomic challenges."
}
]
}
```
